Consumer and clinician perspectives on personalising breast cancer prevention information
LA Keogh, E Steel, P Weideman, P Butow, IM Collins, JD Emery, GB Mann, A Bickerstaffe, AH Trainer, LJ Hopper, KA Phillips
BREAST | CHURCHILL LIVINGSTONE | Published : 2019
BACKGROUND: Personalised prevention of breast cancer has focused on women at very high risk, yet most breast cancers occur in women at average, or moderately increased risk (≤moderate risk). OBJECTIVES: To determine; 1) interest of women at ≤ moderate risk (consumers) in personalised information about breast cancer risk; 2) familial cancer clinicians' (FCCs) perspective on managing women at ≤ moderate risk, and; 3) both consumers' and FCCs reactions to iPrevent, a personalised breast cancer risk assessment and risk management decision support tool. METHODS: Seven focus groups on breast cancer risk were conducted with 49 participants; 27 consumers and 22 FCCs. Data were analysed thematically...View full abstract
Related Projects (1)
Awarded by Australian National Health and Medical Research Council (NHMRC)
This research was funded by the Australian National Health and Medical Research Council (NHMRC) (#1064244). KAP is an Australian National Breast Cancer Foundation Practitioner Fellow. JLH is a NHMRC Senior Principal Research Fellow.